Acknowledging AMR in regulatory frameworks for drug approvals could improve the availability of new antibiotics

By | July 15, 2022
The appropriate use of existing antibiotics and the development of new antibiotics targeting drug-resistant infections can slow the emergence, spread, and consequences of antimicrobial resistance (AMR); however, antibiotic research and development (R&D) has not responded to the urgent need for new antibiotics.